Briacell Therapeutics Corp T.BCT

Alternate Symbol(s): BCTX | BCTXW

BriaCell Therapeutics Corp. is a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care. Bria-IMT, its Phase 3 lead candidate, is a patented, off-the-shelf, cell-based, targeted immunotherapy that activates the patient’s immune system to specifically kill cancer cells without harming other cells. The Company is advancing its Bria-IMT targeted immunotherapy in combination with an immune check point inhibitor (Retifanlimab) in a pivotal Phase 3 study in metastatic breast cancer. It is also developing personalized off-the-shelf immunotherapies, Bria-OTS and Bria-OTS+, which provides a platform technology to develop personalized off-the-shelf immunotherapies for numerous types of cancer, and a soluble CD80 protein therapeutic which act both as a stimulator of the immune system, as well as an immune checkpoint inhibitor. Its pipeline also includes Bria-IMT + CPI, Bria-BRES/BRES+, Bria-PROS+, Bria-LUNG+ and Bria-MEL+.

TSX:BCT - Post by User

Briacell Therapeutics Corp

Bullboard Posts

Comment by Tradertimestwoon Jan 11, 2020 8:35am

74 Views

Post# 30541759

RE:RE:RE:150M$ buyout

True. I've been in and out since 17 cents. Still down plenty. But optimistic the way bids and volume are building. Hopefully people are holding a bit tighter at these levels and very tight share structure. GL2U.

Pugsrock2 wrote: I imagine you would if you had 4 or 5 cent shares. Less attractive when you own 25 cent shares. However a good buyout is much better than the current state of affairs

Bullboard Posts

NervGen Pharma: Proof that NVG-291 works?